VERDERIO, PAOLO
VERDERIO, PAOLO
DIPARTIMENTO DI SCIENZE CLINICHE "LUIGI SACCO" (attivo dal 01/01/2002 al 27/04/2012)
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial
2025 S. Pasquali, P. Collini, C. Romagosa, J. Coindre, S. Pizzamiglio, P. Verderio, V. Duroni, M. Barisella, E. Palmerini, V. Quagliuolo, J. Martin Broto, A.L. Pousa, G. Grignani, A. Brunello, J. Blay, I. Lugowska, V. Fontana, G. Bianchi, E. Palassini, S.L. Renne, P.G. Casali, R. Miceli, M. Sbaraglia, M. Gambarotti, S. Bagué, A.P. Dei Tos, S. Stacchiotti, A. Gronchi
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial
2025 A. Vanzulli, R. Vigorito, C. Buonomenna, E. Palmerini, V. Quagliuolo, J.M. Broto, A. Lopez Pousa, G. Grignani, A. Brunello, J. Blay, R. Diaz Beveridge, V. Ferraresi, I. Lugowska, S. Pizzamiglio, P. Verderio, V. Duroni, V. Fontana, D.M. Donati, E. Palassini, G. Bianchi, A. Bertuzzi, A. Buonadonna, S. Pasquali, A.P. Dei Tos, P.G. Casali, C. Morosi, S. Stacchiotti, A. Gronchi
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)
2024 A. Gronchi, E. Palmerini, V. Quagliuolo, J. Martin Broto, A. Lopez Pousa, G. Grignani, A. Brunello, J. Blay, O. Tendero, R. Diaz Beveridge, V. Ferraresi, I. Lugowska, S. Pizzamiglio, P. Verderio, V. Fontana, D.M. Donati, E. Palassini, R. Sanfilippo, G. Bianchi, A. Bertuzzi, C. Morosi, S. Pasquali, S. Stacchiotti, S. Bagué, J.M. Coindre, R. Miceli, A.P. Dei Tos, P.G. Casali
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis
2024 E. Palassini, G.G. Baldi, C.M. Ciniselli, M. Gennaro, A. Gronchi, C. Sangalli, F. Conforti, P. Collini, A.M. Frezza, I. Pellegrini, A. Allajbej, M. Fiore, C. Morosi, E. Pennacchioli, M. Barisella, P.G. Casali, P. Verderio, T. De Pas, S. Stacchiotti
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression
2024 S. Stacchiotti, S. Martini, S. Pasquali, A.M. Frezza, A. Beretta, S. Percio, M. Lecchi, M. Tortoreto, M. Barisella, P. Collini, G.P. Dagrada, A. Merlini, P.H. Huang, A. Jenks, R.L. Jones, W.D. Tap, M. Ingrosso, C. Morosi, S. Brich, C. Giani, P. Verderio, P.G. Casali, H. Leonard, A. Gronchi, V. Zuco, N. Zaffaroni
Alterations in Plasma Lipid Profiles Associated with Melanoma and Therapy Resistance
2024 M. Dei Cas, C.M. Ciniselli, E. Vergani, E. Ciusani, M. Aloisi, V. Duroni, P. Verderio, R. Ghidoni, R. Paroni, P. Perego, G.L. Beretta, L. Gatti, M. Rodolfo
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab
2022 F. Ligorio, S. Di Cosimo, P. Verderio, C.M. Ciniselli, S. Pizzamiglio, L. Castagnoli, M. Dugo, B. Galbardi, R. Salgado, S. Loi, S. Michiels, T. Triulzi, E. Tagliabue, S. El-Abed, M. Izquierdo, E. de Azambuja, P. Nuciforo, J. Huober, L. Moscetti, W. Janni, M.A. Coccia-Portugal, P.A. Corsetto, A. Belfiore, D. Lorenzini, M.G. Daidone, A. Vingiani, L. Gianni, S.M. Pupa, G. Bianchini, G. Pruneri, C. Vernieri
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples
2022 I. Capone, F. Bozzi, G.P. Dagrada, P. Verderio, E. Conca, A. Busico, M.A. Testi, V. Monti, M. Duca, C. Proto, S. Damian, A. Piccolo, F. Perrone, E. Tamborini, A. Devecchi, P. Collini, D. Lorenzini, A. Vingiani, L. Agnelli, G. Pruneri
Skip pattern approach toward the early access of innovative anticancer drugs
2021 G. Apolone, A. Ardizzoni, A. Biondi, A. Bortolami, C. Cardone, C.M. Ciniselli, P. Conte, C. Crippa, F. de Braud, M. Duca, S. Gori, G. Gritti, A. Inno, R. Luksch, F. Lussana, M. Maio, G. Pasello, F. Perrone, A. Rambaldi, G. Rossi, D. Signorelli, G. Soverini, M. Valente, P. Verderio, G. Buzzetti
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma : revisiting the results of the EORTC-STBSG 62931 randomised trial
2019 S. Pasquali, S. Pizzamiglio, N. Touati, S. Litiere, S. Marreaud, B. Kasper, H. Gelderblom, S. Stacchiotti, I. Judson, A.P. Dei Tos, P. Verderio, P.G. Casali, P.J. Woll, A. Gronchi
Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer
2019 J. Azzollini, C. Pesenti, S. Pizzamiglio, L. Fontana, C. Guarino, B. Peissel, M. Plebani, S. Tabano, S.M. Sirchia, P. Colapietro, R. Villa, B. Paolini, P. Verderio, M. Miozzo, S. Manoukian
Monitoring vitamin B12 in women treated with metformin for primary prevention of breast cancer and age-related chronic diseases
2019 A. Mastroianni, C.M. Ciniselli, R. Panella, A. Macciotta, A. Cavalleri, E. Venturelli, F. Taverna, A. Mazzocchi, E. Bruno, P. Muti, F. Berrino, P. Verderio, D. Morelli, P. Pasanisi
The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study
2019 S. Di Cosimo, T. Triulzi, S. Pizzamiglio, L. De Cecco, E. de Azambuja, D. Fumagalli, L. Putzai, N. Harbeck, M. Izquierdo, L.D.L. Pena, M.G. Daidone, J. Huober, S. Gori, S. Cinieri, V. Torri, J. Baselga, M. Piccart, F.G. de Braud, G. Apolone, P. Verderio, E. Tagliabue
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial
2018 S. Pasquali, C. Colombo, S. Pizzamiglio, P. Verderio, D. Callegaro, S. Stacchiotti, J. Martin Broto, A. Lopez-Pousa, S. Ferrari, A. Poveda, A. De Paoli, V. Quagliuolo, J.C. Jurado, A. Comandone, G. Grignani, R. De Sanctis, E. Palassini, A. Llomboart-Bosch, A.P. Dei Tos, P.G. Casali, P. Picci, A. Gronchi
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS) : long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
2016 A. Gronchi, S. Stacchiotti, P. Verderio, S. Ferrari, J. Martin Broto, A. Lopez-Pousa, A. Llombart-Bosch, A.P. Dei Tos, P. Collini, J. Cruz Jurado, A. De Paoli, D.M. Donati, A. Poveda, V. Quagliuolo, A. Comandone, G. Grignani, C. Morosi, A. Messina, R. De Sanctis, S. Bottelli, E. Palassini, P.G. Casali, P. Picci
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells
2014 P. Verderio, L. Pandolfi, S. Mazzucchelli, M.R. Marinozzi, R. Vanna, F. Gramatica, F. Corsi, M. Colombo, C. Morasso, D. Prosperi
X chromosome inactivation pattern in BRCA gene mutation carriers
2013 S. Manoukian, P. Verderio, S. Tabano, P. Colapietro, S. Pizzamiglio, F.R. Grati, M. Calvello, B. Peissel, J. Burn, V. Pensotti, C. Allemani, S.M. Sirchia, P. Radice, M. Miozzo
Presenza di outlier nei saggi biologici con PCR real-time: L1-norm (LAD) or L2-norm (OLS)?
2011 A. Orenti, P. Verderio
Anchoring peptide nucleic acids (PNAs) to ferrimagnetic iron oxide nanoparticles for DNA targeting
2009 G. Prencipe, E. Licandro, S. Maiorana, D. Prosperi, P. Verderio
Functionalization of Iron Oxide Nanoparticles with Peptide Nucleic Acids (PNAs): synthesis, characterizations and applications
2009 G. Prencipe, E. Licandro, S. Maiorana, D. Prosperi, P. Verderio